￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of the efficacy, role and clinical indications of Eltrombopag (Revlan)

2026-02-01 22:25:32

Check Details
Information about whether Anagrelide has been included in medical insurance

2026-02-01 22:25:32

Check Details
An introduction to what diseases Atrasentan is commonly used to treat

2026-02-01 22:25:32

Check Details
Standard use of elotuzumab

2026-02-01 22:25:32

Check Details
Has bimekizumab been included in medical insurance reimbursement?

2026-02-01 22:25:32

Check Details
Latest news on ensifentrine, improves dyspnea, symptoms and quality of life in patients with chronic obstructive pulmonary disease without exacerbation

2026-02-01 22:25:32

Check Details
Clinical guidelines for the scope of use of everolimus/Afinitor

2026-02-01 22:25:32

Check Details
Can I continue taking Anagrelide after taking it for 20 days?

2026-02-01 22:25:32

Check Details
Information on whether Atrasentan has been officially launched in China

2026-02-01 22:25:32

Check Details
The main mechanism of action of Elotuzumab

2026-02-01 22:25:32

Check Details
Can bimekizumab be used to treat uveitis

2026-02-01 22:25:32

Check Details
Latest official price of ensifentrine - Ohtuvayre market in 2025

2026-02-01 22:25:32

Check Details
Category
相关知识